It is corroborated that rapamycin also exerts a positive effect on the therapy of ALS by a mTOR-dependent pathway, however, its function has been argued that it cannot remove the aggregates apparently in mice expressing abnormal SOD1 [253, 254]. The gene discussed is MTOR; the disease is amyotrophic lateral sclerosis.